h-header

news

News dal mondo

11

Ago

WHO continues work on quality of medicines

The World Health Organization designates new WHO-Listed Authorities, strengthening global access to quality-assured medical products

WHO has officially designated Health Canada, the Ministry of Health, Labour and Welfare/Pharmaceuticals and Medical Devices Agency (MHLW/PMDA) of Japan, and the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products.

With these latest designations, WHO expands the growing list of WLAs, now involving 39 agencies across the world, supporting faster and broader access to quality-assured medical products, particularly in low- and middle-income countries (LMICs)...[WHO]

19

Set

Farmaci, EU: priorità rimediare a carenze

Per la Commissione europea guidata da Ursula von der Leyen rimediare alle carenze di farmaci critici...

19

Set

Testo unico farmaceutica, approvato dal Governo lo schema di disegno legge-delega

Gemmato: 'obiettivo piena attuazione riforma entro legislatura'  "Vogliamo rendere il...

18

Set

Corte Conti UE - Carenza di farmaci: le misure dell’UE hanno fornito un valore aggiunto, ma i problemi strutturali persistono

Nel 2023 e nel 2024 sono stati segnalati livelli record di carenze di medicinali nei paesi dell’UE L’Agenzia...

12

Set

US FDA Commissioner Makary Renews Tough Talk About Instituting Unannounced Foreign Inspections

Foreign drug manufacturers are having a time of it these days. On top of the confusion and controversy...

slider-banner

h-footer